2022 IRIS^® Registry Report

The IRIS^® Registry (Intelligent Research in Sight) is the nation’s first and world’s largest electronic health record-based comprehensive eye disease and condition registry.

In this year's report, we highlight 15 studies that were published in 2022 using IRIS Registry data, we take a closer look at clinic patient volumes as we enter post-COVID clinical care, brand-level market tracking of anti-VEGF agents, and Qdata GA, a curated data set that will spur research in the rapidly developing area of geographic atrophy.

Fill out the form to request a copy of the
2022 IRIS® Registry Report.